Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASHLAND INC.ASH · Entity 4139 | Director | January 30, 2020 | February 03, 2020 |
| Origin Materials, Inc.ORGN · Entity 52695 | Director | December 31, 2025 | January 05, 2026 |
| PPL CorpPPL · Entity 346 | Director | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASHLAND INC.
Report date January 30, 2020 · Filed February 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,882 |
Reported balance
After 2020-01-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-30 · Grant · Acquired 1,449 · Balance 2,882 F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3: Balance includes 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 5 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 5 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 6 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
F2: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)
F3: Balance includes 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 5 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 5 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 6 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019.
Origin Materials, Inc.
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 560,942 |
Reported balance
After 2025-12-31 transaction · row 1
1 source rowRow 1 · 2025-12-31 · Grant · Acquired 33,560 · Balance 560,942 F1: These shares represent the shares of Common Stock underlying restricted stock units ("RSUs") that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, as amended, for the quarter ended December 31, 2025. The number of RSUs received in lieu of cash was calculated based on the average closing price per share of Common Stock for the 60 consecutive trading days ending on and including December 31, 2025. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs are fully vested upon the date of grant. Pursuant to a Deferral Election Form, the Reporting Person elected to defer the receipt of such shares to a future date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent the shares of Common Stock underlying restricted stock units ("RSUs") that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, as amended, for the quarter ended December 31, 2025. The number of RSUs received in lieu of cash was calculated based on the average closing price per share of Common Stock for the 60 consecutive trading days ending on and including December 31, 2025. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs are fully vested upon the date of grant. Pursuant to a Deferral Election Form, the Reporting Person elected to defer the receipt of such shares to a future date.
PPL Corp
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Unit (DDCP)SEC Table II · derivative / convertible security | Direct | 252,171.39 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,335.47 · Balance 252,171.39 F1: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2: Total includes the reinvestment of dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement.
F2: Total includes the reinvestment of dividends.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LANXESS Solutions US Inc.
Report date April 21, 2017 · Filed April 24, 2017
Section 16 reporting ended · disclosed 2017-04-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-04-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-04-21 · Disposition to issuer · Disposed 391,553 · Balance 108,877 F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest (the "Merger Consideration"). Row 2 · 2017-04-21 · Disposition to issuer · Disposed 108,877 · Balance 0 F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest (the "Merger Consideration"). F2: Represents unvested restricted stock units ("RSUs") that were automatically cancelled in connection with the Merger and converted to a deferred cash award in an amount equal to the product of the Merger Consideration and the number of shares represented by such RSUs (the "Deferred Cash Award"). The Deferred Cash Award continues to be subject to the same terms and conditions of the RSUs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the RSUs prior to the Effective Time. |
| Employee Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $16.03 · Expires 2021-03-10 | Direct | 0 |
Reported balance
After 2017-04-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-04-21 · Disposition to issuer · Disposed 197,853 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase Common Stock that was outstanding prior to the Effective Time was cancelled and converted into the right to receive a cash payment equal to the product of (A) the number of shares of Common Stock underlying such option and (B) the excess, if any, of the Merger Consideration over the applicable exercise price of such option. |
| Employee Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $20.50 · Expires 2023-03-01 | Direct | 0 |
Reported balance
After 2017-04-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-04-21 · Disposition to issuer · Disposed 128,241 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase Common Stock that was outstanding prior to the Effective Time was cancelled and converted into the right to receive a cash payment equal to the product of (A) the number of shares of Common Stock underlying such option and (B) the excess, if any, of the Merger Consideration over the applicable exercise price of such option. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-04-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-04-21 · Disposition to issuer · Disposed 207,282 · Balance 0 F4: Represents performance share awards relating to Common Stock ("PSAs") that were automatically converted in connection with the Merger to an amount equal to the product of the Merger Consideration and the number of shares represented by such PSAs, which number is based on the target performance level (the "PS Consideration"); provided, however, that in the case of PSAs for which the applicable performance period had not ended as of the Effective Time, such PSAs were converted to a deferred cash award equal to the PS Consideration and continue to be subject to the same terms and conditions of the PSAs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the PSAs prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest (the "Merger Consideration").
F2: Represents unvested restricted stock units ("RSUs") that were automatically cancelled in connection with the Merger and converted to a deferred cash award in an amount equal to the product of the Merger Consideration and the number of shares represented by such RSUs (the "Deferred Cash Award"). The Deferred Cash Award continues to be subject to the same terms and conditions of the RSUs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the RSUs prior to the Effective Time.
F3: Pursuant to the terms of the Merger Agreement, each option to purchase Common Stock that was outstanding prior to the Effective Time was cancelled and converted into the right to receive a cash payment equal to the product of (A) the number of shares of Common Stock underlying such option and (B) the excess, if any, of the Merger Consideration over the applicable exercise price of such option.
F4: Represents performance share awards relating to Common Stock ("PSAs") that were automatically converted in connection with the Merger to an amount equal to the product of the Merger Consideration and the number of shares represented by such PSAs, which number is based on the target performance level (the "PS Consideration"); provided, however, that in the case of PSAs for which the applicable performance period had not ended as of the Effective Time, such PSAs were converted to a deferred cash award equal to the PS Consideration and continue to be subject to the same terms and conditions of the PSAs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the PSAs prior to the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2018 Filed Jul 3, 2018 18:14 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 2,348.643 | $28.74 | $67,500.00 |
DisclosureSEC source: 0001209191-18-040747 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,117.417 Underlying: Common Stock · 2,348.643 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 14:54 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 2,405.559 | $28.06 | $67,499.99 |
DisclosureSEC source: 0001209191-18-023417 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,295.182 Underlying: Common Stock · 2,405.559 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 20:48 UTC | PPL Corp PPL · Entity 346 | OtherStock Unit (DDCP) · Derivative | 25,136.537 | $27.62 | $694,271.15 |
DisclosureSEC source: 0001209191-18-017972 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,436.699 Underlying: Common Stock · 25,136.537 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · kind: Represents conversion of value under the DDCP, held in the form of a cash equivalent account, to unit equivalents of shares of the Company's Common Stock. F3 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F4 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 18:51 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 2,205.883 | $30.60 | $67,500.02 |
DisclosureSEC source: 0001209191-18-000650 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,300.162 Underlying: Common Stock · 2,205.883 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 16:59 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 1,299.046 | $37.72 | $49,000.02 |
DisclosureSEC source: 0001209191-17-055660 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,175.51 Underlying: Common Stock · 1,299.046 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 13:31 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 1,280.041 | $38.28 | $48,999.97 |
DisclosureSEC source: 0001209191-17-043883 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,152.308 Underlying: Common Stock · 1,280.041 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 09:09 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Disposition to issuerPerformance Shares · Derivative | 207,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-010785 · doc4.xml · derivative · entry 5 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 207,282 shares Expires not disclosed F4 · derivative.exercise_price: Represents performance share awards relating to Common Stock ("PSAs") that were automatically converted in connection with the Merger to an amount equal to the product of the Merger Consideration and the number of shares represented by such PSAs, which number is based on the target performance level (the "PS Consideration"); provided, however, that in the case of PSAs for which the applicable performance period had not ended as of the Effective Time, such PSAs were converted to a deferred cash award equal to the PS Consideration and continue to be subject to the same terms and conditions of the PSAs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the PSAs prior to the Effective Time. F4 · price: Represents performance share awards relating to Common Stock ("PSAs") that were automatically converted in connection with the Merger to an amount equal to the product of the Merger Consideration and the number of shares represented by such PSAs, which number is based on the target performance level (the "PS Consideration"); provided, however, that in the case of PSAs for which the applicable performance period had not ended as of the Effective Time, such PSAs were converted to a deferred cash award equal to the PS Consideration and continue to be subject to the same terms and conditions of the PSAs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the PSAs prior to the Effective Time. F4 · derivative.exercise_date: Represents performance share awards relating to Common Stock ("PSAs") that were automatically converted in connection with the Merger to an amount equal to the product of the Merger Consideration and the number of shares represented by such PSAs, which number is based on the target performance level (the "PS Consideration"); provided, however, that in the case of PSAs for which the applicable performance period had not ended as of the Effective Time, such PSAs were converted to a deferred cash award equal to the PS Consideration and continue to be subject to the same terms and conditions of the PSAs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the PSAs prior to the Effective Time. F4 · derivative.expiration_date: Represents performance share awards relating to Common Stock ("PSAs") that were automatically converted in connection with the Merger to an amount equal to the product of the Merger Consideration and the number of shares represented by such PSAs, which number is based on the target performance level (the "PS Consideration"); provided, however, that in the case of PSAs for which the applicable performance period had not ended as of the Effective Time, such PSAs were converted to a deferred cash award equal to the PS Consideration and continue to be subject to the same terms and conditions of the PSAs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the PSAs prior to the Effective Time. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 09:09 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Disposition to issuerEmployee Stock Option (right to purchase) · Derivative | 128,241 | $13.00 Strike: $20.50 | $1,667,133.00 |
DisclosureSEC source: 0000899243-17-010785 · doc4.xml · derivative · entry 4 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128,241 shares Expires 2023-03-01 F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase Common Stock that was outstanding prior to the Effective Time was cancelled and converted into the right to receive a cash payment equal to the product of (A) the number of shares of Common Stock underlying such option and (B) the excess, if any, of the Merger Consideration over the applicable exercise price of such option. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 09:09 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Disposition to issuerEmployee Stock Option (right to purchase) · Derivative | 197,853 | $17.47 Strike: $16.03 | $3,456,491.91 |
DisclosureSEC source: 0000899243-17-010785 · doc4.xml · derivative · entry 3 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 197,853 shares Expires 2021-03-10 F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase Common Stock that was outstanding prior to the Effective Time was cancelled and converted into the right to receive a cash payment equal to the product of (A) the number of shares of Common Stock underlying such option and (B) the excess, if any, of the Merger Consideration over the applicable exercise price of such option. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 09:09 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Disposition to issuerCommon Stock | 108,877 | $33.50 | $3,647,379.50 |
DisclosureSEC source: 0000899243-17-010785 · doc4.xml · nonDerivative · entry 2 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest (the "Merger Consideration"). F2 · shares: Represents unvested restricted stock units ("RSUs") that were automatically cancelled in connection with the Merger and converted to a deferred cash award in an amount equal to the product of the Merger Consideration and the number of shares represented by such RSUs (the "Deferred Cash Award"). The Deferred Cash Award continues to be subject to the same terms and conditions of the RSUs as in effect immediately prior to the Effective Time and will be paid solely in cash in accordance with the vesting and payment schedule applicable to the RSUs prior to the Effective Time. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 09:09 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Disposition to issuerCommon Stock | 391,553 | $33.50 | $13,117,025.50 |
DisclosureSEC source: 0000899243-17-010785 · doc4.xml · nonDerivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,877 F1 · kind: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest (the "Merger Consideration"). Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 19:42 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 1,320.399 | $37.11 | $49,000.01 |
DisclosureSEC source: 0001209191-17-025547 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,179.066 Underlying: Common Stock · 1,320.399 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:05 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | GrantPerformance Shares · Derivative | 57,982 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006342 · doc4.xml · derivative · entry 3 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,982 Underlying: Common Stock · 57,982 shares Expires 2020-03-01 F2 · derivative.exercise_price: Grant of performance shares. Each performance share represents a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock. The number of shares reported represents the target amount. The actual number of shares to be delivered will be based on Chemtura Corporation's total shareholder return over the three-year vesting period relative to all companies in the Dow Jones US Chemical Index and could equal 200% of the target amount. The performance shares will settle as soon as practicable after December 31, 2019 but no later than March 1, 2020. F2 · derivative.exercise_date: Grant of performance shares. Each performance share represents a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock. The number of shares reported represents the target amount. The actual number of shares to be delivered will be based on Chemtura Corporation's total shareholder return over the three-year vesting period relative to all companies in the Dow Jones US Chemical Index and could equal 200% of the target amount. The performance shares will settle as soon as practicable after December 31, 2019 but no later than March 1, 2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:05 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Tax withholdingCommon Stock | 26,891 | $33.20 | $892,781.20 |
DisclosureSEC source: 0000899243-17-006342 · doc4.xml · nonDerivative · entry 2 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,430 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:05 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | GrantCommon Stock | 47,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006342 · doc4.xml · nonDerivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,321 F1 · shares: Grant of restricted stock units. The restricted stock units vest in three equal installments: March 1, 2018; March 1, 2019; and March 1, 2020. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 16:17 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Exercise / conversionPerformance Shares · Derivative | 85,733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-001449 · doc4.xml · derivative · entry 3 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 126,884 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share was granted in 2014 and represented a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock based on Chemtura Corporation's total shareholder return against the companies comprising the Dow Jones US Chemical Index (the "TSR Metric"). 85,733 shares of common stock represented the target amount of the award granted in 2014. The performance shares vested at 148% of the target amount based on the TSR Metric, for a total payout of 126,884 hares of common stock. F1 · price: Each performance share was granted in 2014 and represented a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock based on Chemtura Corporation's total shareholder return against the companies comprising the Dow Jones US Chemical Index (the "TSR Metric"). 85,733 shares of common stock represented the target amount of the award granted in 2014. The performance shares vested at 148% of the target amount based on the TSR Metric, for a total payout of 126,884 hares of common stock. F1 · derivative.exercise_date: Each performance share was granted in 2014 and represented a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock based on Chemtura Corporation's total shareholder return against the companies comprising the Dow Jones US Chemical Index (the "TSR Metric"). 85,733 shares of common stock represented the target amount of the award granted in 2014. The performance shares vested at 148% of the target amount based on the TSR Metric, for a total payout of 126,884 hares of common stock. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 16:17 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Tax withholdingCommon Stock | 49,008 | $33.15 | $1,624,615.20 |
DisclosureSEC source: 0000899243-17-001449 · doc4.xml · nonDerivative · entry 2 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,881 Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 16:17 UTC | LANXESS Solutions US Inc. CHMT · Entity 176782 | Exercise / conversionCommon Stock | 126,884 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-001449 · doc4.xml · nonDerivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share was granted in 2014 and represented a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock based on Chemtura Corporation's total shareholder return against the companies comprising the Dow Jones US Chemical Index (the "TSR Metric"). 85,733 shares of common stock represented the target amount of the award granted in 2014. The performance shares vested at 148% of the target amount based on the TSR Metric, for a total payout of 126,884 hares of common stock. F2 · balance_after: Includes 337, 347 and 259 shares acquired under the Chemtura Corporation 2012 Employee Stock Purchase Plan on March 31, 2016, June 30, 2016 and September 30, 2016, respectively. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 19:02 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 1,439.906 | $34.03 | $49,000.00 |
DisclosureSEC source: 0001209191-17-001799 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,165.048 Underlying: Common Stock · 1,439.906 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 12:26 UTC | PPL Corp PPL · Entity 346 | GrantStock Unit (DDCP) · Derivative | 1,443.299 | $33.95 | $49,000.00 |
DisclosureSEC source: 0001209191-16-144752 · doc4.xml · derivative · entry 1 ROGERSON CRAIG A · CIK 0001236555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,021.405 Underlying: Common Stock · 1,443.299 shares Expires not disclosed F1 · derivative.exercise_price: No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement. F2 · derivative.exercise_date: Payout of the underlying securities occurs as noted above in Note 1. F2 · derivative.expiration_date: Payout of the underlying securities occurs as noted above in Note 1. F3 · balance_after: Total includes the reinvestment of dividends. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.